Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Papers of the Week
Annotation


Yu H, Saura CA, Choi SY, Sun LD, Yang X, Handler M, Kawarabayashi T, Younkin L, Fedeles B, Wilson MA, Younkin S, Kandel ER, Kirkwood A, Shen J. APP processing and synaptic plasticity in presenilin-1 conditional knockout mice. Neuron. 2001 Sep 13;31(5):713-26. PubMed Abstract, View on AlzSWAN

  
Comments on Paper and Primary News
  Comment by:  Miguel Rodríguez-Manotas
Submitted 22 March 2011  |  Permalink Posted 22 March 2011
  I recommend this paper

Keeping in mind everything that is currently known about PS1 and its main substrate, APP, this paper by Yu et al. was a pioneer in studying the consequences of PS1 inactivation on cognitive deficit. Despite not being recent, there are still some ideas that can be drawn from reading it.

In the cortex of the PS1 cKO mouse, two carboxy-terminal fragments, C89 and C83, were clearly increased as a result of increased availability of substrate, APP, for the cleavage reactions of α- and β-secretase, respectively. Both were elevated by as much as 30-fold (Figure 4 of the paper), whereas C99, another β-secretase cleavage product, was only increased threefold.

Apart from the increased availability of APP for β cleavage, less than half of the total amount of Aβ (Aβ40 and Aβ42) forms in the cortex of PS1 cKO mouse cortex compared to control (Table 2 of paper), because less than half of the amount of C99 is cleaved by γ-secretase. In other words, something has happened with γ cleavage, because PS1 was conditionally knocked out. But in addition, the relatively small increase in C99 is...  Read more

  Submit a Comment on this Paper
Cast your vote and/or make a comment on this paper. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend this paper

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
 
 

REAGENTS/MATERIAL:

Presenilin-1 (PS-1)conditional knockout mouse (cKO) was developed. PS-1 inactivation is restricted to postnatal forebrain.

Western Blot used aPS1loop, (gift of Gopal Thinakaran) 1:10,000; anti-PS2 (GL2) (gift of Takeshi Iwatsubo), 1:1000; and anti-APPs polyclonal anti-APP(C7) (gift of D.Selkoe); polyclonal Saeko (gift of Mikio Shoji) 1:10,000; monoclonal 192, polyclonal 1736; and monoclonal 22C11 (Chemicon).

ELISA assays used the BNT-77/BA27 and BNT-77/BC05 to determine levels of Amyloid-b 40 and 42 in cKO mice. Human mutant APP were measured by 2G3/3D6 and 21F12/3D6 ELISA assays.

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad